Hostname: page-component-7bb8b95d7b-lvwk9 Total loading time: 0 Render date: 2024-09-22T09:26:57.192Z Has data issue: false hasContentIssue false

Seroprevalence of hepatitis B virus, hepatitis C virus and GB virus-C infections in Siberia

Published online by Cambridge University Press:  01 February 1999

K. OHBA
Affiliation:
Second Department of Medicine, Nagoya City University Medical School, Kawasumi 1, Mizuho, Nagoya 467, Japan
M. MIZOKAMI
Affiliation:
Second Department of Medicine, Nagoya City University Medical School, Kawasumi 1, Mizuho, Nagoya 467, Japan
T. KATO
Affiliation:
Second Department of Medicine, Nagoya City University Medical School, Kawasumi 1, Mizuho, Nagoya 467, Japan
R. UEDA
Affiliation:
Second Department of Medicine, Nagoya City University Medical School, Kawasumi 1, Mizuho, Nagoya 467, Japan
V. GURTSENVITCH
Affiliation:
Institute of Carcinogenesis, Cancer Research Center, Moscow, 115478 Russia
N. SENYUTA
Affiliation:
Institute of Carcinogenesis, Cancer Research Center, Moscow, 115478 Russia
A. SYRTSEV
Affiliation:
Institute of Carcinogenesis, Cancer Research Center, Moscow, 115478 Russia Institute of Virus Research, Kyoto University, Kyoto 606, Japan
K. ZOYA
Affiliation:
Oncological Hospital, Petropavlovsk-Kamchatka, 683024 Russia
M. YAMASHITA
Affiliation:
Institute of Virus Research, Kyoto University, Kyoto 606, Japan
M. HAYAMI
Affiliation:
Institute of Virus Research, Kyoto University, Kyoto 606, Japan
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

We studied the seroprevalence of hepatitis B virus (HBV), hepatitis C virus (HCV) and GB virus-C (GBV-C) infections in 348 Siberian natives who lived in the Kamchatka Peninsula of Russia. Of 348 samples studied, the seroprevalence of HBsAg and anti-HBs were 11·8% (41 of 348 samples) and 35·9% (125 of 348 samples), respectively. The prevalence of HCV infection was 1·4% (5 of 348 samples), and that of GBV-C RNA, using RT–PCR methods, was 7·5% (26 of 348 samples). In Siberia, the prevalences of HBV and GBV-C infections were about tenfold higher than those in Japan. The prevalence of HBsAg in subjects under 50 years of age was significantly higher than that in those over 50 years old (P<0·05). Because HBV infection is highly endemic in Siberia, we propose that the community-based mass immunization must be conducted as soon as possible in this area.

Type
Research Article
Copyright
© 1999 Cambridge University Press